MAPK inhibition and growth hormone: a promising therapy in XLH.
Fuente R, Gil-Peña H, Claramunt-Taberner D, Hernández-Frías O, Fernández-Iglesias Á, Alonso-Durán L, Rodríguez-Rubio E, Hermida-Prado F, Anes-González G, Rubio-Aliaga I, Wagner C, Santos F.
Fuente R, et al. Among authors: anes gonzalez g.
FASEB J. 2019 Jul;33(7):8349-8362. doi: 10.1096/fj.201802007R. Epub 2019 Apr 11.
FASEB J. 2019.
PMID: 30974062